| Robert D Lovejoy, CRNA | |
|
379 Stanaford Rd, Beckley, WV 25801-3141 | |
| (304) 253-3000 | |
| Not Available |
| Full Name | Robert D Lovejoy |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 3 Years |
| Location | 379 Stanaford Rd, Beckley, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053695767 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beckley Arh Hospital | Beckley, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Med Surg Physician Group, Inc | 2365710761 | 6 |
| Safe And Sound Anesthesia Services Llc | 6204205412 | 7 |
News Archive
The overuse of antibiotics poses an increasing threat to children who develop - or already have - drug-resistant infections that are difficult or impossible to treat, and can cause extended hospitalization, disability and even death.
OxThera AB, a Stockholm-based privately-held biopharmaceutical company, today announced that it has initiated a clinical study in Primary Hyperoxaluria. This announcement bolsters the Company's position as a leader in developing therapies for hyperoxaluria, a debilitating condition that, if untreated, leads to kidney damage and end-stage renal disease.
Patient assessment of clinical services quality was shown to be an independent predictor of survival for colorectal cancer patients in a study recently published in the Journal of Healthcare Quality, the peer reviewed publication of the National Association for Healthcare Quality (NAHQ), www.nahq.org.
Research from North Carolina State University demonstrates that a relatively new microscopy technique can be used to improve our understanding of human tissues and other biomedical materials. The study focused specifically on eye tissues, which are damaged by scarring in diabetic patients.
The U.S. Food and Drug Administration today approved TachoSil, the first absorbable fibrin sealant patch for use in cardiovascular surgery to prevent mild and moderate bleeding from small blood vessels, when standard surgical techniques are ineffective or impractical.
› Verified 8 days ago
| Entity Name | Charleston Area Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124248752 PECOS PAC ID: 3375441637 Enrollment ID: O20031223000426 |
News Archive
The overuse of antibiotics poses an increasing threat to children who develop - or already have - drug-resistant infections that are difficult or impossible to treat, and can cause extended hospitalization, disability and even death.
OxThera AB, a Stockholm-based privately-held biopharmaceutical company, today announced that it has initiated a clinical study in Primary Hyperoxaluria. This announcement bolsters the Company's position as a leader in developing therapies for hyperoxaluria, a debilitating condition that, if untreated, leads to kidney damage and end-stage renal disease.
Patient assessment of clinical services quality was shown to be an independent predictor of survival for colorectal cancer patients in a study recently published in the Journal of Healthcare Quality, the peer reviewed publication of the National Association for Healthcare Quality (NAHQ), www.nahq.org.
Research from North Carolina State University demonstrates that a relatively new microscopy technique can be used to improve our understanding of human tissues and other biomedical materials. The study focused specifically on eye tissues, which are damaged by scarring in diabetic patients.
The U.S. Food and Drug Administration today approved TachoSil, the first absorbable fibrin sealant patch for use in cardiovascular surgery to prevent mild and moderate bleeding from small blood vessels, when standard surgical techniques are ineffective or impractical.
› Verified 8 days ago
| Entity Name | Sharp Anesthesia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184084485 PECOS PAC ID: 3476852013 Enrollment ID: O20160503000642 |
News Archive
The overuse of antibiotics poses an increasing threat to children who develop - or already have - drug-resistant infections that are difficult or impossible to treat, and can cause extended hospitalization, disability and even death.
OxThera AB, a Stockholm-based privately-held biopharmaceutical company, today announced that it has initiated a clinical study in Primary Hyperoxaluria. This announcement bolsters the Company's position as a leader in developing therapies for hyperoxaluria, a debilitating condition that, if untreated, leads to kidney damage and end-stage renal disease.
Patient assessment of clinical services quality was shown to be an independent predictor of survival for colorectal cancer patients in a study recently published in the Journal of Healthcare Quality, the peer reviewed publication of the National Association for Healthcare Quality (NAHQ), www.nahq.org.
Research from North Carolina State University demonstrates that a relatively new microscopy technique can be used to improve our understanding of human tissues and other biomedical materials. The study focused specifically on eye tissues, which are damaged by scarring in diabetic patients.
The U.S. Food and Drug Administration today approved TachoSil, the first absorbable fibrin sealant patch for use in cardiovascular surgery to prevent mild and moderate bleeding from small blood vessels, when standard surgical techniques are ineffective or impractical.
› Verified 8 days ago
| Entity Name | Med Surg Physician Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063943678 PECOS PAC ID: 2365710761 Enrollment ID: O20170607001206 |
News Archive
The overuse of antibiotics poses an increasing threat to children who develop - or already have - drug-resistant infections that are difficult or impossible to treat, and can cause extended hospitalization, disability and even death.
OxThera AB, a Stockholm-based privately-held biopharmaceutical company, today announced that it has initiated a clinical study in Primary Hyperoxaluria. This announcement bolsters the Company's position as a leader in developing therapies for hyperoxaluria, a debilitating condition that, if untreated, leads to kidney damage and end-stage renal disease.
Patient assessment of clinical services quality was shown to be an independent predictor of survival for colorectal cancer patients in a study recently published in the Journal of Healthcare Quality, the peer reviewed publication of the National Association for Healthcare Quality (NAHQ), www.nahq.org.
Research from North Carolina State University demonstrates that a relatively new microscopy technique can be used to improve our understanding of human tissues and other biomedical materials. The study focused specifically on eye tissues, which are damaged by scarring in diabetic patients.
The U.S. Food and Drug Administration today approved TachoSil, the first absorbable fibrin sealant patch for use in cardiovascular surgery to prevent mild and moderate bleeding from small blood vessels, when standard surgical techniques are ineffective or impractical.
› Verified 8 days ago
| Entity Name | Safe & Sound Anesthesia Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215654553 PECOS PAC ID: 6204205412 Enrollment ID: O20221210000115 |
News Archive
The overuse of antibiotics poses an increasing threat to children who develop - or already have - drug-resistant infections that are difficult or impossible to treat, and can cause extended hospitalization, disability and even death.
OxThera AB, a Stockholm-based privately-held biopharmaceutical company, today announced that it has initiated a clinical study in Primary Hyperoxaluria. This announcement bolsters the Company's position as a leader in developing therapies for hyperoxaluria, a debilitating condition that, if untreated, leads to kidney damage and end-stage renal disease.
Patient assessment of clinical services quality was shown to be an independent predictor of survival for colorectal cancer patients in a study recently published in the Journal of Healthcare Quality, the peer reviewed publication of the National Association for Healthcare Quality (NAHQ), www.nahq.org.
Research from North Carolina State University demonstrates that a relatively new microscopy technique can be used to improve our understanding of human tissues and other biomedical materials. The study focused specifically on eye tissues, which are damaged by scarring in diabetic patients.
The U.S. Food and Drug Administration today approved TachoSil, the first absorbable fibrin sealant patch for use in cardiovascular surgery to prevent mild and moderate bleeding from small blood vessels, when standard surgical techniques are ineffective or impractical.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert D Lovejoy, CRNA 228 Country Way, Tornado, WV 25202-9734 Ph: (304) 444-1278 | Robert D Lovejoy, CRNA 379 Stanaford Rd, Beckley, WV 25801-3141 Ph: (304) 253-3000 |
News Archive
The overuse of antibiotics poses an increasing threat to children who develop - or already have - drug-resistant infections that are difficult or impossible to treat, and can cause extended hospitalization, disability and even death.
OxThera AB, a Stockholm-based privately-held biopharmaceutical company, today announced that it has initiated a clinical study in Primary Hyperoxaluria. This announcement bolsters the Company's position as a leader in developing therapies for hyperoxaluria, a debilitating condition that, if untreated, leads to kidney damage and end-stage renal disease.
Patient assessment of clinical services quality was shown to be an independent predictor of survival for colorectal cancer patients in a study recently published in the Journal of Healthcare Quality, the peer reviewed publication of the National Association for Healthcare Quality (NAHQ), www.nahq.org.
Research from North Carolina State University demonstrates that a relatively new microscopy technique can be used to improve our understanding of human tissues and other biomedical materials. The study focused specifically on eye tissues, which are damaged by scarring in diabetic patients.
The U.S. Food and Drug Administration today approved TachoSil, the first absorbable fibrin sealant patch for use in cardiovascular surgery to prevent mild and moderate bleeding from small blood vessels, when standard surgical techniques are ineffective or impractical.
› Verified 8 days ago
Mr. Landon J Blankenship, APRN, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 456 Cranberry Dr, Beckley, WV 25801 Phone: 304-255-6404 Fax: 304-255-6494 | |
Mrs. Jennifer Elizabeth Poff, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 250 Stanaford Rd, Beckley, WV 25801 Phone: 304-254-2634 Fax: 304-254-2664 | |
Debra L Mcgraw, CFNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1802 Harper Rd, Suite 102, Beckley, WV 25801 Phone: 304-252-9211 Fax: 304-252-9218 | |
Adam L Meade, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4130 Robert C. Byrd Drive, Beckley, WV 25801 Phone: 273-326-3337 | |
Jennifer N Lambert, N.P. Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 306 Stanaford Rd, Beckley, WV 25801 Phone: 304-255-3000 Fax: 954-625-6034 | |
Rosalind Rebecca Berry, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 275 Dry Hill Road, Beckley, WV 25801 Phone: 304-253-6060 Fax: 304-929-2248 | |
Traci Lynn Morris, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 101 S Eisenhower Dr, Beckley, WV 25801 Phone: 304-256-7100 Fax: 304-256-7111 |